Low-molecular-weight Heparins in Therapy of Thromboembolic Diseases
Marcel Dekker Inc (Verlag)
978-0-8247-9174-2 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Detailing the basic and clinical science of low-molecular-weight heparins, this reference assesses the efficacy and safety of using this new class of antithrombotic agents in the prevention and treatment of venous thromboembolism, explaining the advantages of low-molecular-weight heparins, as compared with regular, unfractionated heparins. Containing the contributions of over 25 specialists from Europe and North America, "Low-Molecular-Weight Heparins in prophylaxis and Therapy of Thromboembolic Diseases": investigates the pharmacology, mechanisms of action, and laboratory monitoring of low-molecular-weight heparins; offers a first appraisal of the use of low-molecular-weight heparins in the treatment of established venous thromboembolism; presents systematic overviews of the use of low-molecular-weight heparins in the prevention of venous thromboembolism following general, neuro-, and orthopedic surgery, and in immobilized medical patients, as well as in extracorporeal circuits; and delineates the interactions of low-molecular-weight heparin compounds with endothelial cells, blood platelets, the fibrinolytic system, and the proliferation of smooth muscle tissue.
This resource is intended for: cardiologists; specialists in vascular medicine; hematologists; vascular, cardiovascular, and orthopedic surgeons; anesthesiologists; clinical pharmacologists; pulmonologists; gynecologists; and upper-level undergraduate, graduate, and medical school students in these disciplines.
Pharmacology of unfractionated and low-molecular-weight heparins; mode of action of low-molecular-weight heparins in plasma and its consequences for the clinical laboratory; laboratory control of low-molecular-weight heparins - needs and possibilities; deep venous thrombosis - an overview of diagnosis, treatment, and prevention; interaction of heparins with platelets, including heparin-induced thrombocytopenia; interactions between glycosaminoglycans and endothelial cells; interactions between heparin and fibrinolysis; low-molecular-weight heparins for prevention of venous thromboembolism following general surgery; low-molecular-weight heparins for prevention of venous thromboembolism following orthopaedic surgery; low-molecular-weight heparins and heparinoids for prevention of venous thromboembolism in stroke and neurosurgical patients; low-molecular-weight heparins for prevention of venous thromboembolism in medical patients; low-molecular-weight heparins for prevention of venous thromboembolism following lumbar regional anaesthesia; low-molecular-weight heparins in extracorporeal circuits; low-molecular-weight heparins for prevention of restenosis following coronary angioplasty; low-molecular-weight heparins for treatment of established venous thromboembolism; conclusion - current controversies about low-molecular-weight heparins in prevention and therapy of venous thromboembolism.
| Reihe/Serie | Fundamental and Clinical Cardiology ; v. 19 |
|---|---|
| Zusatzinfo | illustrations |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 165 x 241 mm |
| Gewicht | 635 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Anatomie / Neuroanatomie | |
| ISBN-10 | 0-8247-9174-6 / 0824791746 |
| ISBN-13 | 978-0-8247-9174-2 / 9780824791742 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
